PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $159,791 | -5.8% | 15,409 | +30.1% | 0.00% | 0.0% |
| Q2 2023 | $169,635 | +100.7% | 11,846 | +0.1% | 0.00% | 0.0% |
| Q1 2023 | $84,538 | -35.1% | 11,840 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $130,197 | +7.6% | 11,604 | +6.1% | 0.00% | 0.0% |
| Q3 2022 | $121,000 | +33.0% | 10,933 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $91,000 | -33.6% | 10,778 | +7.2% | 0.00% | 0.0% |
| Q1 2022 | $137,000 | -35.4% | 10,055 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $212,000 | -40.4% | 10,763 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $356,000 | -7.3% | 11,085 | -2.3% | 0.00% | +100.0% |
| Q2 2021 | $384,000 | +51.8% | 11,348 | +68.2% | 0.00% | 0.0% |
| Q1 2021 | $253,000 | +22.2% | 6,747 | +8.0% | 0.00% | 0.0% |
| Q4 2020 | $207,000 | -12.3% | 6,245 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $236,000 | +9.3% | 6,424 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $216,000 | +31.7% | 6,570 | +3.1% | 0.00% | 0.0% |
| Q1 2020 | $164,000 | -21.9% | 6,370 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $210,000 | – | 6,738 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $40,675,000 | 10.18% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $114,625,000 | 8.82% |
| Abingworth LLP | 1,203,135 | $23,606,000 | 5.72% |
| RA Capital Management | 3,115,008 | $61,272,000 | 1.08% |
| Avidity Partners Management LP | 1,896,000 | $37,294,000 | 0.79% |
| StepStone Group LP | 422,085 | $8,302,000 | 0.47% |
| Summit Rock Advisors, LP | 34,100 | $671,000 | 0.40% |
| Parkman Healthcare Partners LLC | 77,481 | $1,524,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 186,210 | $3,624,000 | 0.24% |
| Ikarian Capital, LLC | 74,560 | $1,467,000 | 0.22% |